Purification and characterization of mitogen-activated protein kinase activator(s) from epidermal growth factor-stimulated A431 cells.
about
Molecular cloning, expression, and characterization of the human mitogen-activated protein kinase p44erk1Expression cloning of a human dual-specificity phosphataseA protein factor for ras p21-dependent activation of mitogen-activated protein (MAP) kinase through MAP kinase kinaseN-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasomePurification of a murine protein-tyrosine/threonine kinase that phosphorylates and activates the Erk-1 gene product: relationship to the fission yeast byr1 gene productProtein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cellsIdentification and characterization of a new mammalian mitogen-activated protein kinase kinase, MKK2.RAS and RAF-1 form a signalling complex with MEK-1 but not MEK-2.Mitogen-activated protein kinase kinase 1 (MKK1) is negatively regulated by threonine phosphorylationA conserved docking site in MEKs mediates high-affinity binding to MAP kinases and cooperates with a scaffold protein to enhance signal transmissionCloning of rat MEK kinase 1 cDNA reveals an endogenous membrane-associated 195-kDa protein with a large regulatory domainMEKK1 phosphorylates MEK1 and MEK2 but does not cause activation of mitogen-activated protein kinaseAssociation of MEK1 with p21ras.GMPPNP is dependent on B-Raf.The mitogen-activated protein kinase cascade is activated by B-Raf in response to nerve growth factor through interaction with p21rasBiochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2.The MPM-2 antibody inhibits mitogen-activated protein kinase activity by binding to an epitope containing phosphothreonine-183Activation of the mitogen-activated protein kinase pathway in Triton X-100 disrupted NIH-3T3 cells by p21 ras and in vitro by plasma membranes from NIH 3T3 cells.Novel membrane-targeted ERK1 and ERK2 chimeras which act as dominant negative, isotype-specific mitogen-activated protein kinase inhibitors of Ras-Raf-mediated transcriptional activation of c-fos in NIH 3T3 cells.Metabolic labeling of mitogen-activated protein kinase kinase in A431 cells demonstrates phosphorylation on serine and threonine residues.Molecular structure of a protein-tyrosine/threonine kinase activating p42 mitogen-activated protein (MAP) kinase: MAP kinase kinase.Dual phosphorylation and autophosphorylation in mitogen-activated protein (MAP) kinase activation.New algorithm to determine true colocalization in combination with image restoration and time-lapse confocal microscopy to MAP kinases in mitochondriaActivation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovaniLigation of the T cell receptor complex results in activation of the Ras/Raf-1/MEK/MAPK cascade in human T lymphocytes.MEK-1 phosphorylation by MEK kinase, Raf, and mitogen-activated protein kinase: analysis of phosphopeptides and regulation of activity.Differential effects on cAMP on the MAP kinase cascade: evidence for a cAMP-insensitive step that can bypass Raf-1Interconnected network motifs control podocyte morphology and kidney function.MAP kinase modules: the excursion model and the steps that count.Mitogen-activated protein kinase (MAPK)-docking sites in MAPK kinases function as tethers that are crucial for MAPK regulation in vivo.Genetic analysis of the Caenorhabditis elegans MAP kinase gene mpk-1Differential activation of mitogen-activated protein kinase in response to basic fibroblast growth factor in skeletal muscle cells.Immunosuppression in hamsters with progressive visceral leishmaniasis is associated with an impairment of protein kinase C activity in their lymphocytes that can be partially reversed by okadaic acid or anti-transforming growth factor beta antibodyBaicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathwayThe novel anti-MEK small molecule AZD6244 induces BIM-dependent and AKT-independent apoptosis in diffuse large B-cell lymphomaA requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum.Protein-tyrosine-phosphatase 2C is phosphorylated and inhibited by 44-kDa mitogen-activated protein kinaseShortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells.A 50-kDa ERK-like protein is up-regulated by a dual altered peptide ligand that suppresses myasthenia gravis-associated responses.Nuclear translocation of mitogen-activated protein kinase kinase (MEK1) in response to mitogenic stimulation.Stimulation by phospholipids of a protein-tyrosine-phosphatase containing two src homology 2 domains.
P2860
Q24310254-24304D20-7F63-4994-A35B-DD7F61C7B4AEQ24562377-4FD553D8-85EF-4802-9204-BB67077C8E1DQ24563631-44D0D2F1-A1EA-4430-8C92-11C8E84D7EF1Q24563960-1146F59C-5818-494D-9C05-347CBF8BDD65Q24564113-289C86D5-48D6-4BFC-A64C-FB780755CD8AQ24564451-96671EB4-75FE-4AC1-A04F-62DAEE2B7556Q24602577-6219B139-7150-4ACC-AF70-E16897D753FDQ24607777-A5619C7C-ED98-4324-AC3E-DC91946C9AC4Q24614153-EF025DE1-C8D2-413F-B4A5-EEB4449A9562Q28345384-42BAA608-BE7E-450D-AC57-B4446340CC6AQ28573164-3592BB52-4269-4EED-8AB5-CAF0CB2EB4A2Q28581201-A6553E0E-7CA2-49C7-BB2B-AF085A4A940FQ28583306-E37CCC03-9407-4ACF-A79B-6140EB6AA145Q28609138-5DB7674B-91B7-42DC-B6F2-45266D33E694Q30306546-45B2F1CA-4437-41A3-AE04-F8F8345A5C57Q30450997-7CF28EBC-30EA-4623-B7D9-465D1770101CQ30451011-62328AF7-E8D4-4B20-ABA8-ED02E4565803Q30453600-5013D0EA-C5C7-470E-97DE-18E2A1084EC2Q30454068-765A8C9B-93D9-4267-87C2-387FD5EA1D1CQ30454074-3C3203E6-CAC6-44BF-A617-10E70E853666Q30463790-9D0DEC1A-4155-4449-973A-1ABAC75BCE88Q33895259-A54C668E-86A8-4121-9CC1-47DCD75D13B4Q34001456-E556752E-1C8F-413C-87A8-ECB39F516C61Q34145511-A401E14C-AD81-4E41-AB3F-7317F15F02F8Q34440555-9BF9C924-5CA1-4EE1-BDB7-D688B12B8A80Q34450770-D708A26E-7534-4EDD-9C5F-E79C9892CE8EQ34455351-63265137-602F-459C-BE1A-BD26FEB31C0DQ34467087-4BFE504E-2075-4A0A-8FCB-A0FE30327F04Q34473609-4139A1B2-8165-4ED1-9F1C-16B95CF6F672Q34605401-A24A56C4-B404-4DD0-ABAE-322D971AB6A0Q34743737-82AEE48D-CA82-429E-9C46-148E050CF604Q34934364-41F36A8E-5134-49B1-910F-084E12FBD5CFQ34988660-F2D7C633-5E23-4274-A462-DB927FED25C2Q35140947-63486288-8AE8-4371-A06C-5A3C31B006A4Q35200753-EFD7D785-7BA3-42CE-B601-3EF0D15656A5Q35346084-C57FB52E-D218-4F63-A54F-E7DCB97AF666Q35670500-5AA4EEB6-FB7C-4B82-A771-B61AC17F2208Q35722274-59C64D42-FE51-45DA-9053-92556674AA47Q36105057-C93E9580-0531-4292-A6D1-2B52D345CED3Q36288543-216CFE36-819D-42FB-8B5F-2095A8CDFB1D
P2860
Purification and characterization of mitogen-activated protein kinase activator(s) from epidermal growth factor-stimulated A431 cells.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Purification and characterizat ...... factor-stimulated A431 cells.
@en
type
label
Purification and characterizat ...... factor-stimulated A431 cells.
@en
prefLabel
Purification and characterizat ...... factor-stimulated A431 cells.
@en
P2093
P1476
Purification and characterizat ...... h factor-stimulated A431 cells
@en
P2093
P304
14373-14381
P407
P577
1992-07-01T00:00:00Z